Maiken Gy K.

Maiken Gy K. serves as the Vice President and Head of Global Regulatory Affairs at LEO Pharma since February 2018, overseeing the global regulatory operations across key strategic markets including the USA, Japan, China, Canada, and EU5. Previously, Maiken has held various leadership roles in regulatory affairs, including Vice President & Global Program Head for Tralokinumab, focusing on its development and commercialization for atopic dermatitis. With extensive experience in life-cycle management, Maiken has managed multiple portfolios and strategic projects at companies such as Novo Nordisk, GE Healthcare, Takeda Pharmaceuticals, and Nycomed, gaining expertise in regulatory strategies and integration across global markets. Maiken holds a Master of Pharmaceutical Regulatory Affairs from the University of Copenhagen and has contributed to academia as a lecturer in regulatory affairs.